Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ParaGen Technologies is a private U.S. medical device and tissue engineering company developing synthetic nanofiber scaffold technologies for regenerative medicine applications. The company appears to operate as a parent/platform organization that forms or supports subsidiaries focused on specific clinical verticals including wound care, orthopedics, vascular applications, and hernia repair. Its core technology is designed to mimic native tissue architecture and combine favorable properties of synthetic and biologic implants to support healing and tissue regeneration. Publicly visible materials point to product and product-development activity such as Phoenix Wound Matrix and affiliated entities including RenovoDerm, Vascular Genesis, and Tarian Medical. Overall, ParaGen is better characterized as a regenerative medicine and medical technology platform company than as a therapeutics biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ParaGen Technologies.